PCNA and neoplasm: Analyses of the biomarkers post-treatment with 131I-5-IPN revealed the reduced expression of proliferating cell nuclear antigen (PCNA) and Ki67 as well as the cell cycle blockage in the G2/M phase in tumor tissues.